Search Results
Oxaliplatin-DNA adduct formation in white blood cells of cancer patients
2008, Pieck, A.C., Drescher, A., Wiesmann, K.G., Messerschmidt, J., Weber, G., Strumberg, D., Hilger, R.A., Scheulen, M.E., Jaehde, U.
In this study, we investigated the kinetics of oxaliplatin-DNA adduct formation in white blood cells of cancer patients in relation to efficacy as well as oxaliplatin-associated neurotoxicity. Thirty-seven patients with various solid tumours received 130 mg m−2 oxaliplatin as a 2-h infusion. Oxaliplatin-DNA adduct levels were measured in the first cycle using adsorptive stripping voltammetry. Platinum concentrations were measured in ultrafiltrate and plasma using a validated flameless atomic absorption spectrometry method. DNA adduct levels showed a characteristic time course, but were not correlated to platinum pharmacokinetics and varied considerably among individuals. In patients showing tumour response, adduct levels after 24 and 48 h were significantly higher than in nonresponders. Oxaliplatin-induced neurotoxicity was more pronounced but was not significantly different in patients with high adduct levels. The potential of oxaliplatin-DNA adduct measurements as pharmacodynamic end point should be further investigated in future trials.
Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer
2010, Cadenas, Cristina, Franckenstein, Dennis, Schmidt, Marcus, Gehrmann, Mathias, Hermes, Matthias, Geppert, Bettina, Schormann, Wiebke, Maccoux, Lindsey J., Schug, Markus, Schumann, Anika, Wilhelm, Christian, Freis, Evgenia, Ickstadt, Katja, Rahnenführer, Jörg, Baumbach, Jörg I., Sickmann, Albert, Hengstler, Jan G.
Introduction: The purpose of this work was to study the prognostic influence in breast cancer of thioredoxin reductase 1 (TXNRD1) and thioredoxin interacting protein (TXNIP), key players in oxidative stress control that are currently evaluated as possible therapeutic targets. Methods: Analysis of the association of TXNRD1 and TXNIP RNA expression with the metastasis-free interval (MFI) was performed in 788 patients with node-negative breast cancer, consisting of three individual cohorts (Mainz, Rotterdam and Transbig). Correlation with metagenes and conventional clinical parameters (age, pT stage, grading, hormone and ERBB2 status) was explored. MCF-7 cells with a doxycycline-inducible expression of an oncogenic ERBB2 were used to investigate the influence of ERBB2 on TXNRD1 and TXNIP transcription. Results: TXNRD1 was associated with worse MFI in the combined cohort (hazard ratio = 1.955; P < 0.001) as well as in all three individual cohorts. In contrast, TXNIP was associated with better prognosis (hazard ratio = 0.642; P < 0.001) and similar results were obtained in all three subcohorts. Interestingly, patients with ERBB2-status-positive tumors expressed higher levels of TXNRD1. Induction of ERBB2 in MCF-7 cells caused not only an immediate increase in TXNRD1 but also a strong decrease in TXNIP. A subsequent upregulation of TXNIP as cells undergo senescence was accompanied by a strong increase in levels of reactive oxygen species. Conclusions: TXNRD1 and TXNIP are associated with prognosis in breast cancer, and ERBB2 seems to be one of the factors shifting balances of both factors of the redox control system in a prognostic unfavorable manner.
Grundlagenuntersuchungen zum therapeutischen Einsatz eines atmosphärischen Plasmajets in der Zahnerhaltung, Teilvorhaben 1: Grundlagenuntersuchungen zum Nachweis der Machbarkeit des therapeutischen Einsatzes eines atmosphärischen Plasmajets vorzugsweise in der Zahnerhaltung (IOM); Teilvorhaben 2: Grundlagenuntersuchungen zum Nachweis der Machbarkeit des therapeutischen Einsatzes eines atmosphärischen Plasmajets vorzugsweise in der Zahnerhaltung (Uni Saarland) : Schlussbericht zum BMBF-Verbundprojekt
2010, Rupf, Stefan, Schindler, Axel, Lehmann, Antje
[no abstract available]
Neuartiges Konzept zum Tissue Engineering von langen Röhrenknochen auf der Basis biologisierter Scaffolds - Teilprojekt PHB-Fäden : (Unterprojekt Abt. MF-Erzeugung schmelzgesponnener PHB-Fäden für die textile Verarbeitung) ; Schlussbericht zum Projekt ; im Rahmen des Förderprogramms Innoregio/INNtex
2007, Peitzsch, Lutz, Vogel, Roland, Brünig, Harald, Schmack, Gerhilt
[no abstract available]
Gain of a 500-fold sensitivity on an intravital MR Contrast Agent based on an endohedral Gadolinium-Cluster-Fullerene-Conjugate: A new chance in cancer diagnostics
2010, Braun, Klaus, Dunsch, Lothar, Pipkorn, Ruediger, Bock, Michael, Baeuerle, Tobias, Yang, Shangfeng, Waldeck, Waldemar, Wiessler, Manfred
Among the applications of fullerene technology in health sciences the expanding field of magnetic resonance imaging (MRI) of molecular processes is most challenging. Here we present the synthesis and application of a GdxSc3-xN@C80-BioShuttle-conjugate referred to as Gd-cluster@-BioShuttle, which features high proton relaxation and, in comparison to the commonly used contrast agents, high signal enhancement at very low Gd concentrations. This modularly designed contrast agent represents a new tool for improved monitoring and evaluation of interventions at the gene transcription level. Also, a widespread monitoring to track individual cells is possible, as well as sensing of microenvironments. Furthermore, BioShuttle can also deliver constructs for transfection or active pharmaceutical ingredients, and scaffolding for incorporation with the host's body. Using the Gd-cluster@-BioShuttle as MRI contrast agent allows an improved evaluation of radio- or chemotherapy treated tissues.
Successful downstream application of the Paxgene Blood RNA system from small blood samples in paediatric patients for quantitative PCR analysis
2007, Carrol, Enitan D., Salway, Fiona, Pepper, Stuart D., Saunders, Emma, Mankhambo, Limangeni A., Ollier, William E., Hart, C. Anthony, Day, Phillip
Background: The challenge of gene expression studies is to reliably quantify levels of transcripts, but this is hindered by a number of factors including sample availability, handling and storage. The PAXgene™ Blood RNA System includes a stabilizing additive in a plastic evacuated tube, but requires 2.5 mL blood, which makes routine implementation impractical for paediatric use. The aim of this study was to modify the PAXgene™ Blood RNA System kit protocol for application to small, sick chidren, without compromising RNA integrity, and subsequently to perform quantitative analysis of ICAM and interleukin-6 gene expression. Aliquots of 0.86 mL PAXgene™ reagent were put into microtubes and 0.3 mL whole blood added to maintain the same recommended proportions as in the PAXgene™ evacuated tube system. RNA quality was assessed using the Agilent BioAnalyser 2100 and an in-house TaqMan™ assay which measures GAPDH transcript integrity by determining 3' to 5' ratios. qPCR analysis was performed on an additional panel of 7 housekeeping genes. Three reference genes (HPRT1, YWHAZ and GAPDH) were identified using the GeNORM algorithm, which were subsequently used to normalising target gene expression levels. ICAM-1 and IL-6 gene expression were measured in 87 Malawian children with invasive pneumococcal disease. Results: Total RNA yield was between 1,114 and 2,950 ng and the BioAnalyser 2100 demonstrated discernible 18s and 28s bands. The cycle threshold values obtained for the seven housekeeping genes were between 15 and 30 and showed good consistency. Median relative ICAM and IL-6 gene expression were significantly reduced in non-survivors compared to survivors (ICAM: 3.56 vs 4.41, p = 0.04, and IL-6: 2.16 vs 6.73, p = 0.02). Conclusion: We have successfully modified the PAXgene™ blood collection system for use in small children and demonstrated preservation of RNA integrity and successful quantitative real-time PCR analysis.
Abschlussbericht zum Verbundprojekt Campus PlasmaMed, Teilvorhaben Campus PlasmaMed 6
2011, Weltmann, Klaus-Dieter
[no abstract available]
Identification of Eps15 as antigen recognized by the monoclonal antibodies aa2 and ab52 of the wuerzburg hybridoma library against Drosophila brain
2011, Halder, Partho, Chen, Yi-chun, Brauckhoff, Janine, Hofbauer, Alois, Dabauvalle, Marie-Christine, Lewandrowski, Urs, Winkler, Christiane, Sickmann, Albert, Buchner, Erich
The Wuerzburg Hybridoma Library against the Drosophila brain represents a collection of around 200 monoclonal antibodies that bind to specific structures in the Drosophila brain. Here we describe the immunohistochemical staining patterns, the Western blot signals of one- and two-dimensional electrophoretic separation, and the mass spectrometric characterization of the target protein candidates recognized by the monoclonal antibodies aa2 and ab52 from the library. Analysis of a mutant of a candidate gene identified the Drosophila homolog of the Epidermal growth factor receptor Pathway Substrate clone 15 (Eps15) as the antigen for these two antibodies.
Compomics-utilities: An open-source Java library for computational proteomics
2011, Barsnes, Harald, Vaudel, Marc, Helsens, Kenny, Sickmann, Albert, Walther, Dirk, Berven, Frode S.
The growing interest in the field of proteomics has increased the demand for software tools and applications that process and analyze the resulting data. And even though the purpose of these tools can vary significantly, they usually share a basic set of features, including the handling of protein and peptide sequences, the visualization of (and interaction with) spectra and chromatograms, and the parsing of results from various proteomics search engines. Developers typically spend considerable time and effort implementing these support structures, which detracts from working on the novel aspects of their tool.
Integration der Positronen-Emissions-Tomographie in die Strahlentherapie mit hochenergetischen Photonen
2009, Kunath, Daniela
[no abstract available]